Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattijs Bulcaen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|June 13, 2024
Gene editing flows to the lungsMattijs Bulcaen, Marianne S Carlon
Molecular Therapy. Methods & Clinical Development|January 23, 2024
Genetic surgery for a cystic fibrosis-causing splicing mutationMattijs Bulcaen, Marianne S Carlon
Progress in Molecular Biology and Translational Science|June 27, 2021
Rewriting CFTR to cure cystic fibrosisGiulia Maule, Marjolein Ensinck, Mattijs Bulcaen, et al.
International Journal of Molecular Sciences|May 7, 2025
<i>Cis</i>-Regulation of the <i>CFTR</i> Gene in Pancreatic CellsClara Blotas, Anaïs Le Nabec, Mégane Collobert, et al.
Trends in Molecular Medicine|March 22, 2025
Cystic fibrosis at a glance: from disease mechanism to therapyKasper Gryspeert, Laudonia L Dipalo, Ana L Da Silva Cunha, et al.
STAR Protocols|February 2, 2025
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysisMattijs Bulcaen, Ronald B Liu, Kasper Gryspeert, et al.
Science Translational Medicine|April 22, 2026
Functional correction of the untreatable <i>CFTR</i> 1717-1G>A mutation through mRNA- and sgRNA-optimized base editingAlessandro Umbach, Annalisa Santini, Mattijs Bulcaen, et al.
Nature Biotechnology|May 21, 2026
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editingY Allen Tao, Holt A Sakai, Allen Y Jiang, et al.
Cell Reports. Medicine|May 2, 2024
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cellsMattijs Bulcaen, Phéline Kortleven, Ronald B Liu, et al.
Biosensors & Bioelectronics|March 7, 2022
Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridgeJia-Huan Qu, Henry Ordutowski, Charlotte Van Tricht, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|June 13, 2024
Gene editing flows to the lungsMattijs Bulcaen, Marianne S Carlon
Molecular Therapy. Methods & Clinical Development|January 23, 2024
Genetic surgery for a cystic fibrosis-causing splicing mutationMattijs Bulcaen, Marianne S Carlon
Progress in Molecular Biology and Translational Science|June 27, 2021
Rewriting CFTR to cure cystic fibrosisGiulia Maule, Marjolein Ensinck, Mattijs Bulcaen, et al.
International Journal of Molecular Sciences|May 7, 2025
<i>Cis</i>-Regulation of the <i>CFTR</i> Gene in Pancreatic CellsClara Blotas, Anaïs Le Nabec, Mégane Collobert, et al.
Trends in Molecular Medicine|March 22, 2025
Cystic fibrosis at a glance: from disease mechanism to therapyKasper Gryspeert, Laudonia L Dipalo, Ana L Da Silva Cunha, et al.
STAR Protocols|February 2, 2025
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysisMattijs Bulcaen, Ronald B Liu, Kasper Gryspeert, et al.
Science Translational Medicine|April 22, 2026
Functional correction of the untreatable <i>CFTR</i> 1717-1G>A mutation through mRNA- and sgRNA-optimized base editingAlessandro Umbach, Annalisa Santini, Mattijs Bulcaen, et al.
Nature Biotechnology|May 21, 2026
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editingY Allen Tao, Holt A Sakai, Allen Y Jiang, et al.
Cell Reports. Medicine|May 2, 2024
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cellsMattijs Bulcaen, Phéline Kortleven, Ronald B Liu, et al.
Biosensors & Bioelectronics|March 7, 2022
Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridgeJia-Huan Qu, Henry Ordutowski, Charlotte Van Tricht, et al.
Pageof 2